To determine if H3.3 mutations alter PML-NBs in pediatric gliomas, we assessed PML and H3.3 in two H3.3 K27M mutated patient-derived glioma cell lines (DIPG XIII, BT245). The gene discussed is PML; the disease is central nervous system cancer.